Bandini, Lavinia
 Distribuzione geografica
Continente #
EU - Europa 370
NA - Nord America 298
AS - Asia 70
AF - Africa 26
OC - Oceania 10
SA - Sud America 5
Totale 779
Nazione #
US - Stati Uniti d'America 292
IT - Italia 178
SE - Svezia 67
DE - Germania 38
SG - Singapore 25
AT - Austria 22
BG - Bulgaria 21
CI - Costa d'Avorio 18
CN - Cina 18
IN - India 13
FR - Francia 11
GB - Regno Unito 10
AU - Australia 9
VN - Vietnam 8
DK - Danimarca 7
BR - Brasile 5
GR - Grecia 5
CA - Canada 4
SN - Senegal 4
CZ - Repubblica Ceca 3
NG - Nigeria 3
TR - Turchia 3
HK - Hong Kong 2
MX - Messico 2
RO - Romania 2
UA - Ucraina 2
CH - Svizzera 1
EG - Egitto 1
FI - Finlandia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 779
Città #
Chandler 70
Milan 53
Serra 27
Vienna 22
Fairfield 21
Sofia 21
Frankfurt am Main 19
Abidjan 18
New York 18
Houston 16
Ashburn 15
Florence 14
Woodbridge 14
Princeton 13
Cambridge 11
Pisa 11
Lawrence 10
Wilmington 10
Beijing 9
Bremen 8
Medford 8
Rome 8
Singapore 8
Redwood City 7
Hobart 6
Rødovre 6
Trezzo Sull'adda 6
Dong Ket 5
London 5
Prato 5
Carrara 4
Dakar 4
Guiyang 4
Marseille 4
Norwalk 4
Ogden 4
Ann Arbor 3
Boardman 3
Lagos 3
Lucca 3
New Delhi 3
Pune 3
Seattle 3
Toronto 3
Agerola 2
Cerro Maggiore 2
Gaeta 2
Hong Kong 2
Hyderabad 2
Kocaeli 2
Los Angeles 2
Melbourne 2
Olomouc 2
San Diego 2
Scuola 2
Strasbourg 2
Thrissur 2
Atlanta 1
Auburn 1
Auckland 1
Brno 1
Brooklyn 1
Chicago 1
Dearborn 1
Duncan 1
Edinburgh 1
Genova 1
Helsinki 1
Iasi 1
Istanbul 1
Ivry-sur-Seine 1
Iztapalapa 1
Langhirano 1
Lissone 1
Massa 1
Mexico City 1
Middleton 1
North York 1
Pakenham 1
Portland 1
San Francisco 1
Seveso 1
Southwark 1
Stockholm 1
Suresnes 1
Warsaw 1
Westminster 1
Zurich 1
Totale 569
Nome #
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity 151
ACE2 in the era of SARS-CoV-2: controversies and novel perspectives 110
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 87
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 76
Delivery of thyronamines (Tams) to the brain: A preliminary study 72
null 68
SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS) 67
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 66
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells 47
The 3-iodothyroacetic acid does not cause change in proteins affected by T1AM. 33
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1) 26
3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? 15
Totale 818
Categoria #
all - tutte 2.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202097 0 0 0 0 7 21 9 14 14 17 14 1
2020/2021133 9 3 23 12 11 16 6 12 9 11 9 12
2021/2022118 2 0 0 6 21 14 3 5 9 12 20 26
2022/2023279 40 40 19 23 26 29 1 13 64 2 15 7
2023/2024190 28 24 27 18 23 27 6 6 4 3 10 14
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 818